Materials • Major Chemicals
$7.45 ▼ -0.25
(-3.25%)
MKT CAP: $857.5M • VOL: 364.6K
52W L $4 52W H $9
ROARABLE / RQD
E • 34/100
PIOTROSKI
4 / 9
KRO // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.86B | $1.89B | $1.67B |
| YoY Revenue Growth % | -1.5% | +13.2% | — |
| Gross Profit | $213.0M | $359.3M | — |
| Gross Margin % | 11.5% | 19.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$36.5M | $122.9M | -$56.0M |
| Operating Margin % | -2.0% | 6.5% | -3.4% |
| Net Income (GAAP) | -$110.9M | $86.2M | -$49.1M |
| EBITDA (Normalized) | -$2.2M | $146.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.5M | $72.5M | $5.5M |
| Capital Expenditures (CapEx) | $42.9M | $29.5M | — |
| Free Cash Flow (FCF) | -$40.4M | $43.0M | $5.5M |
| FCF Margin % | -2.2% | 2.3% | 0.3% |
| Return on Invested Capital (ROIC %) | -2.3% | 8.5% | — |
| Cash & Short-Term Equivalents | $33.2M | $106.7M | — |
| Total Debt (Short + Long Term) | $557.4M | $429.1M | — |
| Total Stockholders' Equity | $751.1M | $817.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR KRO.